Andreozzi, Francesco
Magna Graecia University
8 papers on CoChatORCID 0000-0001-9375-1513
Most cited papers
- Verified
Safety issues with glucagon‐like peptide‐1 receptor agonists (pancreatitis, pancreatic cancer and cholelithiasis): Data from randomized controlled trials
Monami, M., Nreu, B., Scatena, A., Cresci, B., Andreozzi, F., Sesti, G., & Mannucci, E. (2017) · Diabetes, Obesity and Metabolism
Diabetes Treatment and ManagementPharmacology and Obesity Treatment
Cited by 243
- Verified
Insulin Secretion in Metabolically Obese, but Normal Weight, and in Metabolically Healthy but Obese Individuals
Succurro, E., Marini, M. A., Frontoni, S., Hribal, M. L., Andreozzi, F., Lauro, R., Perticone, F., & Sesti, G. (2008) · Obesity
Pancreatic function and diabetesDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 158
- Verified
One-Hour Postload Hyperglycemia Is a Stronger Predictor of Type 2 Diabetes Than Impaired Fasting Glucose
Fiorentino, T. V., Marini, M. A., Andreozzi, F., Arturi, F., Succurro, E., Perticone, M., Sciacqua, A., Hribal, M. L., Perticone, F., & Sesti, G. (2015) · The Journal of Clinical Endocrinology & Metabolism
Diabetes, Cardiovascular Risks, and LipoproteinsPancreatic function and diabetes
Cited by 138
- Verified
Clinical inertia is the enemy of therapeutic success in the management of diabetes and its complications: a narrative literature review
Andreozzi, F., Candido, R., Corrao, S., Fornengo, R., Giancaterini, A., Ponzani, P., Ponziani, M. C., Tuccinardi, F., & Mannino, D. (2020) · Diabetology & Metabolic Syndrome
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 128
- Verified
Nonalcoholic fatty liver disease is associated with low circulating levels of insulin-like growth factor-I
Arturi, F., Succurro, E., Procopio, C., Pedace, E., Mannino, G. C., Lugarà, M., Procopio, T., Andreozzi, F., Sciacqua, A., Hribal, M. L., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism
Growth Hormone and Insulin-like Growth FactorsLiver Disease Diagnosis and Treatment
Cited by 103
- Verified
The GLP-1 receptor agonists exenatide and liraglutide activate Glucose transport by an AMPK-dependent mechanism
Andreozzi, F., Raciti, G. A., Nigro, C., Mannino, G. C., Procopio, T., Davalli, A. M., Beguinot, F., Sesti, G., Miele, C., & Folli, F. (2016) · Journal of Translational Medicine
Metabolism, Diabetes, and CancerDiabetes Treatment and Management
Cited by 102
- Verified
Low plasma insulin-like growth factor-1 levels are associated with reduced insulin sensitivity and increased insulin secretion in nondiabetic subjects
Succurro, E., Andreozzi, F., Marini, M. A., Lauro, R., Hribal, M. L., Perticone, F., & Sesti, G. (2009) · Nutrition Metabolism and Cardiovascular Diseases
Growth Hormone and Insulin-like Growth FactorsPancreatic function and diabetes
Cited by 85
- Verified
Sex-specific differences in myocardial glucose metabolic rate in non-diabetic, pre-diabetic and type 2 diabetic subjects
Succurro, E., Vizza, P., Cicone, F., Cassano, V., Massimino, M., Giofrè, F., Fiorentino, T. V., Perticone, M., Sciacqua, A., Guzzi, P. H., et al. (2023) · Cardiovascular Diabetology
Cardiovascular Function and Risk FactorsDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 5
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free